CEPI and Accumulus Synergy team up to enhance information equity and accelerate access to vaccines
10 déc. 2024 06h00 HE
|
Accumulus Synergy
OSLO, Norway and BURLINGAME, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy’s innovative cloud-based data-sharing platform could accelerate access to vaccines and other health...
BioNTech und CEPI erweitern Partnerschaft zur Stärkung des afrikanischen mRNA-Impfstoff-Ökosystems
29 mai 2024 08h00 HE
|
BioNTech SE
BioNTech und die Coalition for Epidemic Prepardness Innovations (CEPI) wollen die lokale Forschung und Entwicklung sowie die klinische und kommerzielle Herstellung potenzieller mRNA-Impfstoffe...
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
29 mai 2024 08h00 HE
|
BioNTech SE
BioNTech and CEPI aim to enhance local R&D, clinical and commercial-scale manufacturing capacities to develop potential mRNA vaccines in Africa, for AfricaCEPI to fund up to $145 million to...
New partnership aims to advance vaccine against MERS coronavirus
21 déc. 2023 07h31 HE
|
Barinthus Biotherapeutics
CEPI to invest funding of up to $34.8 million to Barinthus Bio in addition to funds previously committed to University of Oxford to develop VTP-500
BioNTech und CEPI geben Partnerschaft zur Entwicklung eines mRNA-Mpox-Impfstoffs und zur Unterstützung von CEPIs 100-Tage-Ziel bekannt
18 sept. 2023 06h45 HE
|
BioNTech SE
BioNTech bereitet klinische Phase-1/2-Studie für das mRNA-basierte Mpox-Impfstoffprogramm BNT166 vorDie Coalition for Epidemic Preparedness Innovations (CEPI) stellt bis zu 90 Millionen US-Dollar für...
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
18 sept. 2023 06h45 HE
|
BioNTech SE
BioNTech is initiating a Phase 1/2 clinical trial of the mRNA-based mpox vaccine program, BNT166The Coalition for Epidemic Preparedness Innovations (CEPI) commits funding of up to $90 million for the...
Dyadic's DYAI-100 COVID-19 Vaccine Study Published in a Leading Peer-Reviewed Scientific Journal
14 déc. 2022 08h30 HE
|
Dyadic International, Inc.
“Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge” Study supports: Dyadic’s...
CEPI and Codiak BioSciences partner to develop broadly protective Betacoronavirus vaccine
05 juil. 2022 06h30 HE
|
Codiak BioSciences, Inc.
OSLO, Norway and CAMBRIDGE, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- CEPI, the Coalition for Epidemic Preparedness Innovations, and Codiak BioSciences (NASDAQ: CDAK) today announced the latest...
ADX Labs捐赠十万美元，用于推进新冠疫苗研发
24 juin 2020 08h08 HE
|
ADX Labs, Inc.
总部位于明尼阿波利斯市的科技企业ADX Labs向流行病防范创新联盟（CEPI）慷慨捐款，CEPI将用此笔善款加速新冠病毒候选疫苗的研发工作。 明尼阿波利斯, June 24, 2020 (GLOBE NEWSWIRE) -- ADX Labs向流行病防范创新联盟（CEPI）捐赠10万美元，用于加速新冠疫苗的研发工作。该善款系通过ADX Labs下属的公益机构ADX基金会提供。 ...
ADX Labs donates $100,000 to advance COVID-19 vaccine research
24 juin 2020 08h08 HE
|
ADX Labs, Inc.
The Coalition for Epidemic Preparedness Innovations (CEPI) is accelerating the development of candidate vaccines against COVID-19 with the financial support of Minneapolis-based technology company ADX...